IL79254A0 - Compositions for preventing graft rejection - Google Patents

Compositions for preventing graft rejection

Info

Publication number
IL79254A0
IL79254A0 IL79254A IL7925486A IL79254A0 IL 79254 A0 IL79254 A0 IL 79254A0 IL 79254 A IL79254 A IL 79254A IL 7925486 A IL7925486 A IL 7925486A IL 79254 A0 IL79254 A0 IL 79254A0
Authority
IL
Israel
Prior art keywords
heparin
compositions
graft rejection
humans
preventing graft
Prior art date
Application number
IL79254A
Other languages
English (en)
Original Assignee
Hadassah Med Org
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL79254A priority Critical patent/IL79254A0/xx
Application filed by Hadassah Med Org, Yeda Res & Dev filed Critical Hadassah Med Org
Publication of IL79254A0 publication Critical patent/IL79254A0/xx
Priority to ES87108976T priority patent/ES2052514T3/es
Priority to EP87108976A priority patent/EP0251134B1/en
Priority to DE8787108976T priority patent/DE3782686T2/de
Priority to AT87108976T priority patent/ATE82502T1/de
Priority to NO872675A priority patent/NO872675L/no
Priority to AU74706/87A priority patent/AU608228B2/en
Priority to DK331287A priority patent/DK169422B1/da
Priority to CA000540717A priority patent/CA1318591C/en
Priority to JP62159514A priority patent/JP2527749B2/ja
Priority to US07/583,851 priority patent/US5206223A/en
Priority to GR930400069T priority patent/GR3006814T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
IL79254A 1986-06-26 1986-06-26 Compositions for preventing graft rejection IL79254A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection
ES87108976T ES2052514T3 (es) 1986-06-26 1987-06-23 Un procedimiento para la preparacion de composiciones farmaceuticas eficaces contra enfermedades autoinmunes.
EP87108976A EP0251134B1 (en) 1986-06-26 1987-06-23 Compositions for preventing graft rejection
DE8787108976T DE3782686T2 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastik-abstossung.
AT87108976T ATE82502T1 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastikabstossung.
NO872675A NO872675L (no) 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer
AU74706/87A AU608228B2 (en) 1986-06-26 1987-06-25 Compositions for preventing graft rejection
DK331287A DK169422B1 (da) 1986-06-26 1987-06-26 Anvendelse af heparin, N-desulfateret, N-acetyleret heparin eller O-desulfateret, N-acetyleret heparin til fremstilling af et farmaceutisk præparat, som er effektivt over for autoimmune sygdomme, til lindring af sådanne sygdomme og til behandling af autoimmune sygdomme i pattedyr, herunder mennesker, og til hindring eller forsinkelse af allotransplantatudstødelse
CA000540717A CA1318591C (en) 1986-06-26 1987-06-26 Composition containing heparin or derivative thereof
JP62159514A JP2527749B2 (ja) 1986-06-26 1987-06-26 移植拒否反応抑制または自己免疫疾患治療用薬学的組成物
US07/583,851 US5206223A (en) 1986-06-26 1990-09-17 Method for inhibiting heparanase activity
GR930400069T GR3006814T3 (ja) 1986-06-26 1993-01-14

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Publications (1)

Publication Number Publication Date
IL79254A0 true IL79254A0 (en) 1986-09-30

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Country Status (10)

Country Link
EP (1) EP0251134B1 (ja)
JP (1) JP2527749B2 (ja)
AT (1) ATE82502T1 (ja)
AU (1) AU608228B2 (ja)
DE (1) DE3782686T2 (ja)
DK (1) DK169422B1 (ja)
ES (1) ES2052514T3 (ja)
GR (1) GR3006814T3 (ja)
IL (1) IL79254A0 (ja)
NO (1) NO872675L (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
DE69835016T2 (de) * 1997-07-14 2007-06-28 Muramatsu, Takashi, Nagoya Verwendung von midkin oder von anti-midkin antikörper
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
MXPA04002217A (es) 2001-09-12 2004-07-08 Sigma Tau Ind Farmaceuti Derivados de glucosaminoglucanas parcialmente desulfatados como inhibidores de heparanasa, dotados con actividad antiangiogenica y libres de efectos anticoagulantes.
EP1748781B1 (en) 2004-05-27 2012-12-19 Baxter International Inc. Methods for treating bleeding disorders using sulfated polysaccharides
EP2326334A2 (en) 2008-08-22 2011-06-01 Baxter Healthcare SA Methods for treating bleeding disorders
AU2011205271B2 (en) 2010-01-14 2014-01-30 Baxalta GmbH Methods and compositions for treating bleeding disorders
WO2013012954A2 (en) 2011-07-19 2013-01-24 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
EP2885642B1 (en) 2012-08-14 2019-05-15 Baxalta GmbH Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
US9265791B2 (en) 2013-03-12 2016-02-23 Baxalta GmbH Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
CN108367023B (zh) * 2015-06-11 2021-04-20 马斯特里赫特大学 预防宿主中移植物衰竭的方法

Also Published As

Publication number Publication date
DE3782686T2 (de) 1993-06-09
JPS6388127A (ja) 1988-04-19
JP2527749B2 (ja) 1996-08-28
ATE82502T1 (de) 1992-12-15
NO872675D0 (no) 1987-06-25
GR3006814T3 (ja) 1993-06-30
ES2052514T3 (es) 1994-07-16
DK169422B1 (da) 1994-10-31
AU608228B2 (en) 1991-03-28
EP0251134B1 (en) 1992-11-19
EP0251134A3 (en) 1989-05-03
DE3782686D1 (de) 1992-12-24
AU7470687A (en) 1988-01-07
EP0251134A2 (en) 1988-01-07
DK331287D0 (da) 1987-06-26
NO872675L (no) 1987-12-28
DK331287A (da) 1987-12-27

Similar Documents

Publication Publication Date Title
IL79254A0 (en) Compositions for preventing graft rejection
ZA858676B (en) Method and system for removing immunosppressive components from the blood of mammals
DK602387A (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
ES2152998T3 (es) Agente anticomplementario obtenido a partir de fucanos de algas pardas.
TNSN87021A1 (fr) Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
ATE190496T1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
GR79015B (ja)
ZA884936B (en) Edible plastic disperson
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
ZA9010080B (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
GR3017358T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants.
WO1992004359A3 (en) Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
EP0347907A3 (de) Antithrombosemittel auf Basis von derivatisiertem Heparin
Kaiser Importance of corticosteroids in the treatment of infectious diseases.
DE3270466D1 (en) Pharmaceutical composition